Holmes Biopharma, a provider of clinical development services, has signed a $1.2 million dollar contract with a large East Asian pharmaceutical company.
Subscribe to our email newsletter
The contract establishes Holmes Biopharma with another major multinational pharmaceutical company, generating substantial phase I clinical trial revenue for the Omaha operation. Furthermore, this contract is a significant revenue source for Holmes Biopharma’s Data Management Center in Toronto, Canada.
John Metcalfe, president and CEO of Holmes Biopharma, said: “We are just beginning to realize the potential of this highly profitable component of the clinical research business.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.